Acetylcholine Receptor Binding Antibody

The Acetylcholine Receptor Binding Antibody test contains 1 test with 1 biomarker.

Myasthenia Gravis (MG) is a neuromuscular disorder characterized by muscle weakness, most commonly due to autoantibody-mediated loss of functional acetylcholine receptors (AChR) in the neuromuscular junction. This assay aids in the differential diagnosis of MG-like muscle weakness, in differentiating between generalized MG and ocular MG, and in monitoring therapeutic response. If binding antibodies are negative, assays for blocking and modulating antibodies should be considered.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: AChR Antibody, Muscle nicotinic Acetylcholine Receptor (AChR) Binding Antibody, Myasthenia Gravis Antibodies

Acetylcholine Receptor